Geron Corp (GERN) stock
GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 2/30
$1.00+0.06 (+6.17%)
Close on Nov 17, 2026Market cap $642.47MP/E –Yield –
Geron operating margin
Operating margin is operating income as a percentage of revenue.
Geron's operating margin for the twelve months ending Sep 30, 2024 was -705.5%. For fiscal 2023 it was -81832.9%, against -23246.6% the year before. The highest annual figure on record is -1.5% in fiscal 2015.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -81832.9% | −58586.3 |
| FY2022 | Dec 31, 2022 | -23246.6% | −15062.9 |
| FY2021 | Dec 31, 2021 | -8183.7% | +22216.7 |
| FY2020 | Dec 31, 2020 | -30400.4% | −14638.4 |
| FY2019 | Dec 31, 2019 | -15762.0% | −12847.0 |
| FY2018 | Dec 31, 2018 | -2914.9% | −168.0 |
| FY2017 | Dec 31, 2017 | -2746.9% | −2249.6 |
| FY2016 | Dec 31, 2016 | -497.3% | −495.8 |
| FY2015 | Dec 31, 2015 | -1.5% | +3147.8 |
| FY2014 | Dec 31, 2014 | -3149.3% | −112.9 |
| FY2013 | Dec 31, 2013 | -3036.5% | −387.6 |
| FY2012 | Dec 31, 2012 | -2648.9% | +1293.5 |
| FY2011 | Dec 31, 2011 | -3942.4% | −822.4 |
| FY2010 | Dec 31, 2010 | -3120.0% | +949.1 |
| FY2009 | Dec 31, 2009 | -4069.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -21.7% | +20.4 |
| Q1 FY2026 | Mar 31, 2026 | 0.3% | +100.1 |
| Q3 FY2025 | Sep 30, 2025 | -29.4% | +7831.5 |
| Q2 FY2025 | Jun 30, 2025 | -25.4% | +18439.7 |
| Q1 FY2025 | Mar 31, 2025 | -42.2% | +235997.0 |
| Q3 FY2024 | Sep 30, 2024 | -99.8% | +28931.9 |
| Q2 FY2024 | Jun 30, 2024 | -7860.9% | +171280.5 |
| Q1 FY2024 | Mar 31, 2024 | -18465.1% | +172449.2 |
| Q4 FY2023 | Dec 31, 2023 | -236039.1% | −195310.0 |
| Q3 FY2023 | Sep 30, 2023 | -29031.7% | −15581.2 |
| Q2 FY2023 | Jun 30, 2023 | -179141.4% | −140818.1 |
| Q1 FY2023 | Mar 31, 2023 | -190914.3% | −167601.3 |
| Q4 FY2022 | Dec 31, 2022 | -40729.1% | −37750.1 |
| Q3 FY2022 | Sep 30, 2022 | -13450.5% | +10103.6 |
| Q2 FY2022 | Jun 30, 2022 | -38323.3% | −11324.2 |
| Q1 FY2022 | Mar 31, 2022 | -23313.0% | −2543.7 |
| Q4 FY2021 | Dec 31, 2021 | -2979.0% | +43553.0 |
| Q3 FY2021 | Sep 30, 2021 | -23554.1% | −5021.7 |
| Q2 FY2021 | Jun 30, 2021 | -26999.1% | +11982.3 |
| Q1 FY2021 | Mar 31, 2021 | -20769.3% | +11673.0 |
| Q4 FY2020 | Dec 31, 2020 | -46532.0% | −28983.5 |
| Q3 FY2020 | Sep 30, 2020 | -18532.4% | −6340.0 |
| Q2 FY2020 | Jun 30, 2020 | -38981.4% | −23908.1 |
| Q1 FY2020 | Mar 31, 2020 | -32442.3% | −12616.0 |
| Q4 FY2019 | Dec 31, 2019 | -17548.5% | −14991.5 |
| Q3 FY2019 | Sep 30, 2019 | -12192.4% | −8068.1 |
| Q2 FY2019 | Jun 30, 2019 | -15073.3% | −11591.5 |
| Q1 FY2019 | Mar 31, 2019 | -19826.3% | −17487.6 |
| Q4 FY2018 | Dec 31, 2018 | -2557.1% | +1519.4 |
| Q3 FY2018 | Sep 30, 2018 | -4124.2% | +319.9 |
| Q2 FY2018 | Jun 30, 2018 | -3481.7% | +386.7 |
| Q1 FY2018 | Mar 31, 2018 | -2338.7% | −943.1 |
| Q4 FY2017 | Dec 31, 2017 | -4076.4% | +5265.0 |
| Q3 FY2017 | Sep 30, 2017 | -4444.2% | −4368.3 |
| Q2 FY2017 | Jun 30, 2017 | -3868.4% | – |
| Q1 FY2017 | Mar 31, 2017 | -1395.5% | – |
| Q4 FY2016 | Dec 31, 2016 | -9341.5% | – |
| Q3 FY2016 | Sep 30, 2016 | -75.9% | – |
See a number that looks wrong?